Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 22,385 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded Jun 8 to Jun 10, 2026 · Filed Jun 10, 2026

From Jun 8 to Jun 10, 2026, Pham Quang X (Director, Chairman, CEO and Interim CFO, 10% owner) sold 22,385 Cadrenal Therapeutics, Inc. shares at an average US$4.17 for US$93,294 under a trading plan, leaving 150,839 shares. Filed Jun 10, 2026 (Form 4).

Sold
22,385 shares
Price
US$4.17 average (US$4.06 to US$4.38)
Value
US$93,294
Holding after
150,839 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairman, CEO and Interim CFO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 8, 2026Common StockSale5,893US$4.38167,331Direct
Jun 9, 2026Common StockSale12,992US$4.06154,339Direct
Jun 10, 2026Common StockSale3,500US$4.21150,839Direct

Source

View original at SEC

Related